drugset / Trial / NCT00245440

Study to Measure the Impact of Antibiotics on Bacterial Flora in Adults With Acute Sinusitis

NCT00245440 ↗

Phase 4 Terminated 192 enrolled CPL Associates Sanofi · collab
RandomizedParallel-groupOpen-labelDiagnostic

Summary

The purpose of this study is to measure the speed of microbial eradication due to azithromycin or telithromycin in acute maxillary sinusitis (AMS).

Timeline

Start
2005-12
Primary completion
—
Completion
2006-07

Outcome

Outcome not reported

Stopped: “Sponsor Terminated”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 500 mg —
Comparator Telithromycin Small molecule 800 mg Oral

Indications